Second trimester ultrasounds of fetal anomalies in the abdomen, spine, genitourinary, and extremities
A collection of ultrasounds for fetal anomalies in abdominal structures, genitourinary structures, spine, and extremities.
Around 18 to 20 weeks, it's possible to evaluate most anatomic structures using detailed ultrasound. For more information on using ultrasound for the detection of fetal anomalies, click here. Here are 14 ultrasounds taken in the second trimester showing anomalies in the abdominal structures, genitourinary structures, spine, and extremities.
Figure 25. Second trimester small omphalocele
Figure 26. Second trimester gastroschisis
Figure 27. Second trimester ectopic pelvic kidney
Figure 28. Second trimester multicystic dysplastic kidney
Figure 29. Second trimester autosomal recessive infantile polycystic kidneys
Figure 30. Second trimester sagittal view of lumbosacral spina bifida
Figure 31. Second trimester transverse view of sacral spina bifida
Figure 32. Second trimester hemivertebra
Figure 33. Second trimester limb reduction defect (absent fingers)
Figure 34. Second trimester skeletal dysplasia (short and bowed limbs)
Figure 35: Second trimester syndactyly (hand)
Figure 36. Second trimester club-foot
Figure 37. Second trimester example of clenched hands
Figure 38. Second trimester skeletal dysplasia (example of a bell-shaped chest)
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
ACOG release new practice update on biomarker testing for hypertensive disorders in pregnancy
July 24th 2024Padmashree Woodham, MD, professor of maternal-fetal medicine at Wellstar Medical College of Georgia Health, outlines the new ACOG practice update on biomarker testing for risk assessment of hypertensive disorders in pregnancy.
Read More
